Medicare Advantage Growth Hits Record Low as PDP Enrollment Surges
Event summary
- Medicare Advantage (MA) membership reached 35.5 million as of April 1, 2026, with growth slowing to a record low of 2.4%.
- Stand-alone Prescription Drug Plans (PDPs) saw the highest enrollment increase since 2013, adding 1.8 million members (7.8% growth).
- Six of the top ten MA companies experienced year-over-year declines, with an overall net gain of just 1.5%.
- Texas gained approximately 95,000 MA members, while North Carolina saw the largest PDP membership increase with over 189,000 new enrollees.
The big picture
The divergence between MA and PDP growth rates reflects broader shifts in the Medicare landscape, including regulatory changes and insurer strategies. While MA penetration remains strong, the slowdown suggests potential challenges in sustaining past growth trajectories. Meanwhile, the surge in PDP enrollment highlights increasing demand for standalone prescription drug coverage, possibly driven by employer-based plan adjustments.
What we're watching
- Market Penetration
- Whether the slowdown in MA growth signals a saturation point or a shift in consumer preferences.
- Regulatory Impact
- How CMS policies may influence the split of MA-PD plans into medical and stand-alone PDPs.
- State-Specific Trends
- The pace at which states like Texas and North Carolina continue to drive enrollment changes.